Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Feroce

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Human Genetics : EJHG|May 18, 2017
The perceived impact of the European registration system for genetic counsellors and nursesMilena Paneque, Ramona Moldovan, Christophe Cordier, et al.
Maturitas|February 28, 2006
Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRTDavide Serrano, Luigi Mariani, Serena Mora, et al.
Genes, Chromosomes & Cancer|February 5, 2014
Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndromeValeria Molinaro, Valeria Pensotti, Monica Marabelli, et al.
Nutrients|April 30, 2021
Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional CohortValentina Aristarco, Harriet Johansson, Sara Gandini, et al.
Breast Cancer Research and Treatment|January 10, 2012
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsCaterina Fumagalli, Giancarlo Pruneri, Paola Possanzini, et al.
Oncology Letters|August 10, 2017
Hereditary diffuse gastric cancer in two families: A case reportIrene Feroce, Davide Serrano, Roberto Biffi, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2017
BRCA1/2 germline missense mutations: a systematic reviewGiovanni Corso, Irene Feroce, Mattia Intra, et al.
Tumori|January 20, 2025
<i>MLH1</i> promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of <i>MLH1</i> gene?Laura Cazzaniga, Cristina Zanzottera, Sara Mannucci, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Human Genetics : EJHG|May 18, 2017
The perceived impact of the European registration system for genetic counsellors and nursesMilena Paneque, Ramona Moldovan, Christophe Cordier, et al.
Maturitas|February 28, 2006
Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRTDavide Serrano, Luigi Mariani, Serena Mora, et al.
Genes, Chromosomes & Cancer|February 5, 2014
Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndromeValeria Molinaro, Valeria Pensotti, Monica Marabelli, et al.
Nutrients|April 30, 2021
Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional CohortValentina Aristarco, Harriet Johansson, Sara Gandini, et al.
Breast Cancer Research and Treatment|January 10, 2012
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsCaterina Fumagalli, Giancarlo Pruneri, Paola Possanzini, et al.
Oncology Letters|August 10, 2017
Hereditary diffuse gastric cancer in two families: A case reportIrene Feroce, Davide Serrano, Roberto Biffi, et al.
Contemporary Clinical Trials|August 20, 2010
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodologyMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2017
BRCA1/2 germline missense mutations: a systematic reviewGiovanni Corso, Irene Feroce, Mattia Intra, et al.
Tumori|January 20, 2025
<i>MLH1</i> promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of <i>MLH1</i> gene?Laura Cazzaniga, Cristina Zanzottera, Sara Mannucci, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.
Pageof 4